Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McGill University

$105,000.00

Novel tests and biomarkers for the diagnosis and treatment monitoring of tuberculosis

FY 2008-09

Summary
Background One third of the world's population is infected with tuberculosis. TB control strategies in countries such as Canada and the USA depend upon accurate diagnosis and treatment of latent TB infection (LTBI) to prevent new cases of disease. The development of a new blood based test called Interferon gamma release assays (IGRAs) have been shown to be more specific in diagnosing TB infection and potentially useful as an indicator of treatment success. Objectives The objective of this doctoral research is to explore the potential usefulness of the new tests and other biological markers for diagnosing TB infection and determining treatment success. Methods The research involves three components. The first involves evaluating the accuracy and reliability of the new tests. This will be conducted in health care workers from the McGill University Health Centre, who undergo regular screening for TB infection. The second component involves investigating the test in individuals exposed to persons with active TB disease to explore test's usefulness in identifying individuals at higher risk of developing infection. The final component explores using this new test and others as indicators of treatment success and will build on an ongoing study of treatment efficacy. Results and Conclusion Results will address several important areas including TB infection, diagnosis and treatment, and contribute to knowledge concerning accurate interpretation of this new test, particularly among health care workers in Canada. Study conclusions will aid in targeting limited resources towards groups at high risk of developing infection post exposure. If these new test prove useful as indicators of treatment success, it would be a breakthrough for the investigation of new drugs and treatment regimens for TB, allowing for smaller trials with shorter follow-up time. This research has exciting potential implications for public health care globally and here in Canada.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184489
Name
Zwerling Alice A
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Population and Public Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Doctoral Research Awards - B
Projecttitle
Novel tests and biomarkers for the diagnosis and treatment monitoring of tuberculosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Diagnostics Research; Global Health; Latent Tb Infection; Public Health; Tuberculosis Epidemiology
Abstract
Background One third of the world's population is infected with tuberculosis. TB control strategies in countries such as Canada and the USA depend upon accurate diagnosis and treatment of latent TB infection (LTBI) to prevent new cases of disease. The development of a new blood based test called Interferon gamma release assays (IGRAs) have been shown to be more specific in diagnosing TB infection and potentially useful as an indicator of treatment success. Objectives The objective of this doctoral research is to explore the potential usefulness of the new tests and other biological markers for diagnosing TB infection and determining treatment success. Methods The research involves three components. The first involves evaluating the accuracy and reliability of the new tests. This will be conducted in health care workers from the McGill University Health Centre, who undergo regular screening for TB infection. The second component involves investigating the test in individuals exposed to persons with active TB disease to explore test's usefulness in identifying individuals at higher risk of developing infection. The final component explores using this new test and others as indicators of treatment success and will build on an ongoing study of treatment efficacy. Results and Conclusion Results will address several important areas including TB infection, diagnosis and treatment, and contribute to knowledge concerning accurate interpretation of this new test, particularly among health care workers in Canada. Study conclusions will aid in targeting limited resources towards groups at high risk of developing infection post exposure. If these new test prove useful as indicators of treatment success, it would be a breakthrough for the investigation of new drugs and treatment regimens for TB, allowing for smaller trials with shorter follow-up time. This research has exciting potential implications for public health care globally and here in Canada.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zwerling, Alice A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McGill University - $105,000 Grant (2008-09) | Canada Spends